BHC - Bausch Health Companies Inc.
| Previous close | 13.58 |
| Open | 13.55 |
| Bid | 13.03 x 800 |
| Ask | 13.46 x 1400 |
| Day's range | 12.97 - 14.06 |
| 52-week range | 11.15 - 31.97 |
| Volume | 6,828,087 |
| Avg. volume | 5,110,698 |
| Market cap | 4.733B |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.08 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 09 Nov 2010 |
| 1y target est | 30.47 |
- Zacks
Why Is Bausch (BHC) Down 46.5% Since Last Earnings Report?
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Insider Buying: Richard DeSchutter Just Spent US$185k On Bausch Health Companies Inc. (NYSE:BHC) Shares
Potential Bausch Health Companies Inc. (NYSE:BHC) shareholders may wish to note that insider Richard DeSchutter...
- Simply Wall St.
Bausch Health Companies Inc. Just Released Its Annual Results And Analysts Are Updating Their Estimates
Bausch Health Companies Inc. (NYSE:BHC) shares fell 4.5% to US$26.50 in the week since its latest full-year results...
- Zacks
Bausch Health (BHC) Meets Q4 Earnings Estimates
Bausch (BHC) delivered earnings and revenue surprises of 0.00% and -0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Should You Buy Bausch Health (BHC) Ahead of Earnings?
Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Should Value Investors Pick Bausch Health (BHC) Stock Now?
Is Bausch Health (BHC) a great pick from the value investor's perspective right now? Read on to know more.
- Zacks
Aerie's (AERI) Application for Roclanda Accepted in Europe
European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.
- Zacks
5 Reasons Why Ironwood Stock Should Be in Your Portfolio
We provide five reasons which makes Ironwood (IRWD) a good investment option in 2020.
- Zacks
Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris
Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.
- Simply Wall St.
If You Had Bought Bausch Health Companies (NYSE:BHC) Stock Three Years Ago, You Could Pocket A 109% Gain Today
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
- Zacks
Are You Looking for a Top Momentum Pick? Why Bausch Health (BHC) is a Great Choice
Does Bausch Health (BHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks
Is Bausch Health (BHC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks
Why Is Bausch (BHC) Up 8.2% Since Last Earnings Report?
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Bausch (BHC) Might be Well Poised for a Surge
Bausch (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- Zacks
Moving Average Crossover Alert: Bausch Health Companies
Bausch Health Companies is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- Zacks
Top Ranked Value Stocks to Buy for November 26th
Top Ranked Value Stocks to Buy for November 26th
- Zacks
Generic Drugmakers Gain as Price-Fixing Probe Nears an End
Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.
- Zacks
Will Bausch Health Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor Bausch Health.
- Zacks
Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed
Aerie (AERI) posts a wider-than-expected Q3 loss and lowers guidance.
- Zacks
Bausch (BHC) Moves to Buy: Rationale Behind the Upgrade
Bausch (BHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
